Searched for
CHINA S CANSINO
China launches a COVID-19 vaccine inhaled through the mouthThe vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals,...- CanSino's inhaled Covid-19 vax gets emergency use nod in ChinaThe inhaled version of Cansino's adenovirus-vectored Covid-19 vaccine has obtained the green light from the National Medical Products Admin...
- WHO clears China's CanSino COVID vaccine for emergency useThe CanSino vaccine uses a harmless virus called an adenovirus to deliver the spike protein of the coronavirus into the body, which then pr...
- Pfizer to seek COVID-19 vaccine approval in Mexico for children aged 12-15"Pfizer will submit the request for authorization from Cofepris for the vaccine, applicable to minors between 12 and 15 years old, in the n...
- Pakistan to start importing CanSino COVID-19 vaccine for commercial sale this weekPakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the com...
- Pakistan not planning to buy COVID-19 vaccines; to rely on herd immunity and donated jabsSo far, four vaccines -Sinophram (China), Oxford-AstraZeneca (UK), Sputnik-V (Russia) and Cansino Bio (China) have been registered in the c...
- Pakistan approves fourth COVID-19 vaccineChinese company Cansino Biologics Inc's vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday.
- Pakistan: China to gift half million doses of Sinopharm vaccine"They have said send your aircraft and airlift this vaccine immediately. So this is a happy bit of news for us, and we will hopefully be su...
- China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
- China to vaccinate 50 million people for Lunar New Year - SCMPChina has granted emergency-use status to two candidate vaccines from Sinopharm and one from Sinovac Biotech. It has approved a fourth, fro...
- Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
- Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
- Russia aims to launch mass production of coronavirus vaccine doses by 2021The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...
- No country for Chinese vaccine: China's big drug maker not able to conduct overseas trialsIf history is any guide, domestic use-only could be a path for China: An Ebola vaccine, also jointly developed by CanSino and the military ...
- Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyIn the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developmen...
- China firm uses workers to 'pre-test' coronavirus vaccine in global raceChina has positioned itself to be a strong contender. Eight of the nearly two dozen potential vaccines in various stages of human testing w...
- China's CanSino in talks for COVID-19 vaccine Phase III trial overseasChina's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countri...
- 'At war time speed', China leads COVID-19 vaccine raceWhile a laggard in the global vaccine industry, China, where the new coronavirus is thought to have originated, has brought state, military...
- How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...
- China's Tianjin CanSino Biotechnology to mass produce Ebola vaccineInvestment into the base totals 2 billion yuan (about USD 317 million) and construction will be complete in September, 2018.
Load More
